1,2-cyclohexanediamine has been researched along with Cancer of Colon in 2 studies
1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morales, F | 1 |
| Ramírez, A | 1 |
| Morata-Tarifa, C | 1 |
| Navarro, SA | 1 |
| Marchal, JA | 1 |
| Campos, JM | 1 |
| Conejo-García, A | 1 |
| Schmidt, W | 1 |
| Chaney, SG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer[NCT01396707] | Phase 2 | 55 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for 1,2-cyclohexanediamine and Cancer of Colon
| Article | Year |
|---|---|
Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation | 2017 |
Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclohexylamines; DNA Repair; DNA, Neoplasm; Dr | 1993 |